• YLQ
• Product, Reagent and Kit
• Jul, 14, 2021
• No Comments

Introduction To order Documents Related Products Introduction LNP-0315 is a lipid nanoparticle (LNP) formulated with ALC-0315, DSPC, Cholesterol, and ALC-0159.  LNP-0315 is formulated at optimal molar ratio for efficient delivery of mRNA-based vaccines. LNP-0315 is supplied at 10 mg/mL stock solution in ethanol. For research use only.   To order Buy Cat.No. Product name Size Price LP008-1 LNP-0315 1 mL […]

• YLQ
• Product, Reagent and Kit
• Jul, 14, 2021
• No Comments

Introduction To order Documents Related Products Introduction LNP-102 is a lipid nanoparticle (LNP) formulated with SM-102, DSPC, Cholesterol, and DMG-PEG2000.  LNP-102 is formulated at optimal molar ratio for efficient delivery of mRNA-based vaccines. LNP-102 is supplied at 10 mg/mL stock solution in ethanol. For research use only.   To order Buy Cat.No. Product name Size Price LP007-1 LNP-102 1 […]

• YLQ
• Product, Reagent and Kit
• Jul, 14, 2021
• No Comments

Introduction To order Documents Related Products Introduction 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) is a neutral phospholipid containing 18:1 fatty acids at the sn–1 and sn–2 positions. The compound displays sensitivity towards pH change. At acidic it is an inverted hexagonal micelle and transforms to spherical micelle at alkaline pH. DOPE can be used as an emulsifier to facilitate DNA-liposome complex […]

• YLQ
• Product, Reagent and Kit
• Jul, 14, 2021
• No Comments

Introduction To order Documents Related Products Introduction 1,2-Distearoyl-sn-glycero-3-phosphorylcholine (DSPC) is a phospholipid containing the saturated long-chain (18:0) stearic acid inserted at the sn–1 and sn–2 positions. It has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Formulations containing DSPC have been used in the development of lipid nanoparticles for the delivery of […]

• YLQ
• Product, Reagent and Kit
• Jul, 14, 2021
• No Comments

Introduction To order Documents Related Products Introduction DMG-PEG(2000) is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Formulations containing DMG-PEG(2000) have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines. For research use only.     Technical Information   Formal […]

• YLQ
• Product, Reagent and Kit
• Jul, 14, 2021
• No Comments

Introduction To order Documents Related Products Introduction ALC-0159 is a PEG/lipid conjugate (i.e. PEGylated lipid), specifically, it is the N,N-dimyristylamide of 2-hydroxyacetic acid, O-pegylated to a PEG chain mass of about 2 kilodaltons. It is a non-ionic surfactant by its nature. It has been deployed in the Pfizer-BioNTech SARS-CoV-2 mRNA vaccine that contains the active ingredient tozinameran. For research use only.     Technical Information   Formal Name: […]

• YLQ
• Product, Reagent and Kit
• Jul, 14, 2021
• No Comments

Introduction To order Documents Related Products Introduction ALC-0315 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). ALC-0315 has been used in the development of lipid nanoparticles for delivery of mRNA-based vaccines. For research use only.     Technical Information   Formal Name: […]

• YLQ
• Product, Reagent and Kit
• Jul, 14, 2021
• No Comments

Introduction To order Documents Related Products Introduction SM-102 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). SM-102 has been used in the development of lipid nanoparticles for delivery of mRNA-based vaccines. For research use only.     Technical Information   Formal Name: […]